34
Participants
Start Date
June 30, 2014
Primary Completion Date
June 30, 2020
Study Completion Date
June 30, 2020
NUsurface® Meniscus Implant
The NUsurface Meniscus Implant is a Polycarbonate-Urethane (PCU)-based device reinforced with high tensile Ultra High Molecular Weight Polyethylene (UHMWPE) fibers. The product is available in different sizes, left and right, and with trials so as to allow the surgeon several size options for implantation. The NUsurface® Meniscus Implant, is designed to be conceptually analogous to the natural meniscus whose structural characteristics include a highly orientated collagen fiber network supports the large hoop stresses to produce better distribution of contact pressures within the knee joint. Restoring the distribution of joint loads post-meniscectomy is thought to reducing joint overload and to reducing pain.
NSAID's and Non-surgical Treatment Options
Non-prescription drugs, creams, vitamins, and supplements, Prescription or Non-Prescriptions NSAIDs, Non-weight bearing and/or open chain physical therapy or self-administered exercise
Intra-Articular Injections with Corticosteroids
Intra-articular injection of a corticosteroid, such as 40 mg of Triamcinolone (e.g. Aristocort or Kenalog).
Intra-Articular Injections with Hyaluronic Acid (HA)
Intra-articular injection of a hyaluronic acid treatment, such as SYNVISC® HA Injections.
Ospedale Sacro Cuore - Don Calabria, Negrar
Ichilov Hospital, Tel Aviv
Academisch Ziekenhuis Maastricht, Maastricht
Assaf Harofeh Medical Center, Ẕerifin
University Hospital of Munich, Munich
AZ Monica, Antwerp
Centre Hospitalier de Versailles, Le Chesnay
Lead Sponsor
Active Implants
INDUSTRY